Clearmind Medicine’s obesity drug shows positive results in a pre-clinical trialClearmind Medicine, a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major...
SOUL trial: Oral semaglutide demonstrates a 14% reduction in risk of major adverse CV events2 days ago